By Manufacturing Process

PCR-Based / Sanger / Legacy Methods Market Analysis

Cross-industry research covering PCR-Based / Sanger / Legacy Methods across 1 market reportspanning Pharmaceuticals & Life Sciences – Molecular Diagnostics / Consumer Genomics.

1 Reports
1 Industries

Reports Covering PCR-Based / Sanger / Legacy Methods

Direct to Consumer Genetic Sequencing Market to Reach USD 4.7 Billion by 2033 at 7.2% CAGR

Pharmaceuticals & Life Sciences – Molecular Diagnostics / Consumer Genomics·Market: USD 2.7 Billion (2025)·CAGR: 7.2%

Sanger confirmation and PCR-based single-variant tests persist in narrow clinical applications (e.g., confirmatory BRCA testing) but are in structural decline as NGS panel economics improve.

5%

Market Share

1.2%

Segment CAGR

Explore More Segments

Browse all market segments across our research coverage.

View all segments